FDA Panel Recommends Diabetes Drugs Highlight Heart Failure Risk

Article

An FDA advisory panel recommends adding a warning about the potential risk for heart failure to the labels of saxagliptin (Onglyza), saxagliptin/metformin (Kombiglyze), and alogliptin (Nesina).

An FDA advisory panel recommends adding a warning about the potential risk for heart failure to the labels of 2 of AstraZeneca’s diabetes treatments, saxagliptin (Onglyza) and saxagliptin/metformin (Kombiglyze), as well as Takeda's diabetes drug, alogliptin (Nesina).

Still, the regulatory panelists said the 3 dipeptidyl peptidase-4 inhibitors have acceptable heart safety profiles.

The panel’s decisions were partially based on the findings of a heart study involving approximately 16,000 patients that did not demonstrate an increased risk of heart attack with Onglyza compared with placebo. However, data from an AstraZeneca trial suggested the use of the drug was associated with a higher rate of heart failure.

Additionally, a preliminary FDA review determined Onglyza was associated with an increased risk of all-cause death. While the panelists were concerned by these findings, they could not identify a common cause of death.

A separate FDA review of Nesina found the drug was associated with an increase in hospitalizations for heart failure compared with placebo, though the difference was not deemed statistically significant.

Related Videos
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image Credit: Pixel-Shot | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.